Printer Friendly

MEDIVATORS REPORTS THIRD QUARTER

 MEDIVATORS REPORTS THIRD QUARTER
 CANNON FALLS, Minn., Nov. 9 /PRNewswire/ -- MediVators, Inc.


(NASDAQ: MVAT) reported sales for the third quarter ended Sept. 30, 1992, increased 125 percent to $476,163 versus $211,035 in the comparable quarter. The company generated a net loss of $291,676 or $.10 per share for the third quarter of 1992 compared to a net loss of $84,244 or $.05 per share in the 1991 third quarter. For the nine months ended Sept. 30, 1991 sales were $1,340,662 which produced a net loss of $785,945 or $.28 per share compared to sales of $1,244,642 and net income of $54,017 or $.04 per share in the comparable period.
 Curtis D. Luebke, chairman of the board, stated, "In 1992 we expanded the organization in preparation for the introduction of the new dual scope disinfector ("DSD-91"). Unfortunately, we have spent the year waiting for the FDA's 510(k) pre-market notification on the DSD-91. On July 20, 1992, the company responded to the FDA's request for additional information and we are waiting for the FDA to review the file."
 On Nov. 1, 1992, the company licensed from Stanford University the technology and patents for an electrically articulated endoscopic joint. "The articulation technology could dramatically improve the steerability and reliability of endoscopes and endoscope accessories. We are developing a prototype joint which should be completed by the end of the year," according to Donald L. Sturtevant, president.
 MediVators designs, manufactures and markets endoscopic infection control and medical waste disposable equipment and supplies.
 MEDIVATORS, INC.
 Consolidated Statements of Operations
 (Unaudited)
 Three Months Ended Nine Months Ended
 9/30/92 9/30/91 9/30/92 9/30/91
 Sales $476,163 $211,035 $1,340,662 $1,244,642
 Cost of sales 302,087 111,984 778,358 473,890
 Gross profit 174,076 99,051 562,304 770,752
 Operating expenses
 Marketing 106,450 75,763 384,607 314,425
 Research & development 87,140 7,435 182,707 20,087
 General & administrative 322,025 100,612 858,503 371,961
 Operating income
 (loss) (341,539) (84,759) (863,513) 64,279
 Nonoperating income
 (expense) 49,863 515 77,568 (10,262)
 Income (loss) before
 income taxes &
 extraordinary item (291,676) (84,244) (785,945) 54,017
 Extraordinary item --
 tax benefit of net
 operating loss
 carry forward -- -- -- 10,000
 Net income (loss) $(291,676) $(84,244) $(785,945) $54,017
 Net income (loss) per share:
 Income (loss) before
 extraordinary item $(.10) $(.05) -- $.03
 Extraordinary item -- -- (.28) .01
 -- $(.10) $(.05) $(.28) $.04
 Weighted average common
 shares outstanding 2,846,494 1,346,543 2,846,494 1,346,543
 -0- 11/9/92
 /CONTACT: Curtis D. Luebke, chairman of the board, or Donald L. Sturtevant, president and CEO, 507-263-4721, both of MediVators/
 (MVAT) CO: MediVators, Inc. ST: Minnesota IN: MTC SU: ERN


AL -- MN017 -- 8952 11/09/92 17:44 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 9, 1992
Words:486
Previous Article:CHIQUITA DECLARES DIVIDEND ON DEPOSITARY SHARES
Next Article:NEW YORK STOCK EXCHANGE CLOSING, MONDAY, NOV. 9 /PRN/
Topics:


Related Articles
MEDIVATORS, INC. FINANCIAL RESULTS
MEDIVATORS, INC. ANNOUNCES EARNINGS
MEDIVATORS, INC. REPORTS SECOND QUARTER RESULTS
MEDIVATORS, INC. REPORTS THIRD QUARTER RESULTS
MEDIVATORS, INC. REPORTS RESULTS
MEDIVATORS ANNOUNCES QUARTERLY RESULTS
MEDIVATORS ANNOUNCES RESULTS
Cantel Industries, Inc. Announces Earnings of $.10 Per Share for the Quarter vs. Prior Year Loss of $.23 Per Share
Cantel Industries, Inc. Announces Earnings of $.10 Per Share for the Quarter vs. Prior Year Loss of $.23 Per Share
CANTEL REPORTS 20% INCREASE IN INCOME FOR 4TH QUARTER.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters